1. Introduction {#sec1}
===============

Pain has debilitating effects on function, quality of life, and public health costs \[[@B1], [@B2]\]. Complementary and integrative health nonpharmacologic mind and body interventions are commonly being used by doctors of chiropractic, osteopathic physicians, and physical therapists to alleviate and manage pain in adults \[[@B3]\]. One of these interventions, spinal manipulative therapy, is broadly divided into spinal manipulation and spinal mobilization approaches \[[@B4]\]. Results from both spinal manipulation and spinal mobilization studies in asymptomatic and symptomatic individuals demonstrate short-term pain relief both remote and local to the anatomical treatment site following a single treatment \[[@B5]--[@B16]\].

Recently, the American Pain Society proposed optimizing the use of currently available pain treatments as a goal of their Pain Research Agenda \[[@B17]\]. Additionally, a goal of the National Institutes of Health National Center for Complementary and Integrative Health is to improve complementary and integrative interventions\' efficacy for alleviating pain by identifying their mechanisms of action \[[@B18]\]. Essential to achieving these goals is basic science research that uses simulated spinal manipulative therapy techniques with experimental pain models. In the first of such studies, the remote antinociceptive effects of simulated spinal mobilization were determined in adult rats with inflammatory hindpaw nociception \[[@B19]\]. Three minutes of spinal mobilization was delivered to 6 restrained rats at approximately 2 Hertz (Hz) with the experimenter\'s finger over the lumbar (L5) spinous process beginning 10 minutes after intraplantar hindpaw injection of a mixture of endogenous inflammatory mediators. Pressure pain thresholds of the inflamed hindpaws were increased (decreased mechanical sensitivity) immediately after spinal mobilization ended. However, pressure pain thresholds of the experimental treated group 15 minutes later were not different from those of the control nontreated group. While this peripheral inflammatory pain model allowed for a demonstration of an immediate remote antinociceptive effect following spinal mobilization, investigating the effect\'s duration requires a model with longer-lasting nociception. Previous remote efficacy and mechanistic studies of knee joint mobilization used ankle joint and gastrocnemius muscle inflammatory pain models where nociception lasted for hours and weeks \[[@B20]--[@B24]\]. To build upon the findings from the study of spinal mobilization\'s antinociceptive effects on inflamed hindpaw nociception \[[@B19]\], we chose to use the formalin test to produce hindpaw inflammatory pain remote to the anatomical treatment site. The formalin test is a commonly used model of peripheral pain that has been performed in rodents, cats, and monkeys \[[@B25]--[@B27]\]. This test involves a subcutaneous injection of dilute formalin into a paw that leads to tissue inflammation and nonreflexive, spontaneous nociceptive behaviors \[[@B25], [@B28], [@B29]\]. Adult rat nociceptive behaviors of the injected hindpaw are biphasic depending upon whether formalin is subcutaneously injected into the plantar or dorsal paw and the formalin concentration \[[@B30]--[@B35]\]. An acute phase of nociceptive behaviors happens within minutes following formalin injection. A quiescent interphase occurs approximately 5 to 10 minutes after injection and is followed by a persistent or tonic phase that lasts for at least 30 minutes.

Spinal manipulation can be subdivided into high velocity thrust and low velocity nonthrust approaches based upon the presence or absence of a manipulative thrust, repetitions, and/or the duration of treatment \[[@B36]\]. High velocity low amplitude spinal manipulation (HVLA-SM) is typically delivered with a single, short duration thrust \[[@B37]\]. The frequently utilized \[[@B38]\] low velocity variable amplitude spinal manipulation (LVVA-SM) is applied multiple times without thrust delivery in a controlled cyclical manner to a broader anatomical area \[[@B39]\]. We chose to simulate LVVA-SM since both LVVA-SM and spinal mobilization share clinical similarities and are commonly used across manual therapy disciplines \[[@B40]\]. Moreover, both have been found to be efficacious for managing low back pain \[[@B39], [@B41]--[@B44]\]. Typically during a single treatment, LVVA-SM is delivered to an individual lying prone on a treatment table that is divided into stationary rostral and moveable caudal sections \[[@B39], [@B43], [@B45]--[@B47]\]. The clinician applies pressure with one hand in a rostral direction to a vertebra\'s spinous process contact point while controlling the duration, amplitude, and rate of vertebral column flexion via the table\'s movable section ([Figure 1](#fig1){ref-type="fig"}). It is thought that LVVA-SM\'s applied loads open the intervertebral space and/or foramen leading to changes in the anatomy and physiology of the vertebral column, intervertebral discs, and/or adjacent tissues \[[@B39], [@B43], [@B48]\].

The purpose of this study was to determine for the first time the antinociceptive effects of a single simulated LVVA-SM treatment on adult rat remote nociceptive behavior during the commonly used formalin test. Demonstration of antinociceptive effects would warrant using this experimental approach to study mechanisms of spinal manipulative therapy action.

2. Materials and Methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

All methods were approved by the Institutional Animal Care and Use Committee. A total of 32 male Sprague Dawley rats (278--415 g, Harlan Laboratories, Indianapolis, IN, USA) were pair-housed with environment enrichment in a room on a 12-hour light and dark cycle. Access to food and water was ad libitum. One week of housing acclimatization with daily handling occurred before the experiments started.

2.2. Effect of LVVA-SM on Nociceptive Behavior during the Formalin Test {#sec2.2}
-----------------------------------------------------------------------

To reduce novel environment stress \[[@B49], [@B50]\], all rats were habituated at the same time of the morning 2 days prior to and the day of the formalin test for 15 minutes in the behavior assessment laboratory (21-22°C, low level of incandescent illumination, and white conversational noise). This was followed by 30 minutes in the observation chamber (23 cm long, 25 cm wide, and 30 cm high, above a mirror angled to aid viewing the hindpaws). The rats were gently placed into a plastic restraint cone (Stoelting Co., Wood Dale, IL) after the last habituation session. Their right hindpaw was held and 50 *μ*L of freshly made formalin (5% v/v of 37% by weight formaldehyde, Fisher Scientific, Fair Lawn, NJ, diluted in sterile saline) was injected from a 1 mL TB syringe through a 30G(1/2)′′ needle into the plantar subcutaneous space at the tori center \[[@B25], [@B33], [@B51]\]. The rats were placed into the observation chamber immediately following injection. Behavior was video-recorded with a Sanyo Dual Camera Xacti FH1 for 5 minutes after injection during the acute phase of the formalin test.

During 5--10 minutes after injection (interphase), each rat was placed into an induction chamber and anesthetized with isoflurane (3%, Butler Schein Animal Health, Dublin, OH) in oxygen (2 L/min) for 2 minutes to abolish righting and corneal reflexes. The rat was placed prone on a custom-made device \[[@B52]\] ([Figure 2](#fig2){ref-type="fig"}). The device\'s caudal moveable section was in a neutral position. A water circulating heating pad lays underneath the rat over the device\'s rostral stationary section. Anesthesia with isoflurane (1.5%) and oxygen (1 L/min) was continued through an anesthesia nose cone attached to the stationary section. A tooth bar within the nose cone was positioned caudal to the incisors to stabilize the rat\'s head. The rat\'s L5 vertebra was positioned over the table\'s fulcrum point. The forelimbs, hindlimbs, and tail were naturally extended away from the body. A silk suture was gently tied over a piece of Velcro brand tape placed around the base of the tail of rats undergoing LVVA-SM (formalin + LVVA-SM, *n* = 12). The suture was draped over a pulley and a 100 g weight was hung from the other end to provide mild traction to the vertebral column. Beginning 10 minutes after formalin injection, LVVA-SM was administered for a clinically relevant duration of 10 minutes \[[@B53]\] at a rate of 0.14 Hz with the device\'s caudal moveable section cyclically lowered and raised 20° a total of 82 times by a computer-controlled motor. As performed clinically, constant mild pressure was applied in the rostral direction during LVVA-SM by an experimenter\'s finger placed on the rat\'s back at the level of the L5 spinous process. Isoflurane in oxygen (1 L/min) was delivered at concentrations of 1.5%, 1%, and 0% during the first 8 minutes, the ninth minute, and the tenth minute of LVVA-SM, respectively. Following 10 minutes of LVVA-SM at 20 minutes after injection, the rats were returned to their cages placed on heating pads to recover from anesthesia. Control rats (formalin + no LVVA-SM, *n* = 12) underwent the exact same methods except that there was no vertebral column traction, cyclic caudal section movement, or manual contact applied by the experimenter. All rats were ambulatory by 25 minutes after injection. At this time, they were placed in the observation chamber and their behavior was video-recorded for 60 minutes. This recording duration was chosen to distinguish between changes in the magnitude or temporal profile of the formalin test\'s persistent phase \[[@B54]\] after LVVA-SM. In addition, this assessment duration was previously used in efficacy and mechanistic studies of knee joint mobilization on rat hindlimb nociception after joint and muscle inflammation \[[@B20], [@B23], [@B24]\]. Each rat was subsequently euthanized by an intraperitoneal injection of Fatal-Plus (0.88 mL/kg, Vortech Pharmaceuticals Ltd., Dearborn, MI) followed by a thoracotomy \[[@B55]\].

Using VLC media player (Version 2.1.2, VideoLAN Organization) and a personal computer, the time (seconds) each rat spent licking the injected hindpaw was quantified during 1--5 minutes after injection (acute phase) and during three 20 minute bins beginning 25 minutes after injection (persistent phase), that is, 5 minutes after being removed from the LVVA-SM device to 65 minutes post-LVVA-SM or no LVVA-SM. We quantified hindpaw licking time due to this nociceptive behavior occurring during both of these phases of the formalin test \[[@B31]\]. Moreover, decreases in hindpaw licking times have been demonstrated to occur in adult rats undergoing other nonpharmacologic interventions administered prior to formalin injection, such as acupuncture, electroacupuncture, and repetitious swimming exercise in warm water \[[@B51], [@B56], [@B57]\].

2.3. Statistical Methods {#sec2.3}
------------------------

Data analyses were done in SAS/STAT (release 9.3; SAS Institute, Inc., Cary, NC). A linear mixed model of the natural log transformation of hindpaw licking time, with a compound symmetry covariance matrix, was used to establish the formalin test. A linear mixed model with an unstructured covariance and terms for group, bin, and group × bin interaction was used to compare mean licking time between the experimental group that received LVVA-SM (formalin + LVVA-SM) and the control group that received no LVVA-SM (formalin + no LVVA-SM) during the formalin test. The model was also used to compare means across time, for adjacent bins, within each group. A *P* \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Formalin Test {#sec3.1}
------------------

To establish the formalin test in our laboratory, rats received a unilateral intraplantar hindpaw injection of either formalin (*n* = 4) or saline (*n* = 4). The rats spent very little time licking the saline-injected hindpaw during 60 minutes after injection. Significantly greater mean time was spent licking the formalin-injected hindpaw than the saline-injected hindpaw during the 1--5 minutes postinjection acute phase of the formalin test (*P* = 0.007). After a quiescent interphase, 5--10 minutes post-formalin injection, the mean licking times of the formalin-injected hindpaw during the test\'s persistent phase increased and plateaued within 10--25 minutes after injection and then decreased. Significantly greater mean time was spent licking the formalin-injected hindpaw than the saline-injected hindpaw during each 5 minutes for 5--35 minutes after injection (*P* \< 0.001). There was a borderline significant difference between the groups at 40 minutes after injection (*P* = 0.07). Mean licking times of the formalin-injected and saline-injected hindpaws were not significantly different after 40 minutes after injection. These results are consistent with those previously reported from a study using the same formalin concentration, injection volume, and injection site \[[@B33]\].

3.2. Effect of LVVA-SM on Nociceptive Behavior during the Formalin Test {#sec3.2}
-----------------------------------------------------------------------

There was a significant group × bin interaction (*F* ~3,22~ = 18.7, *P* = 0.003), so the main effects of group and bin time could not be analyzed separately. The mean times spent licking the formalin-injected hindpaw 1--5 minutes after injection were not significantly different between the groups (*P* = 0.25) ([Figure 3](#fig3){ref-type="fig"}). The mean time spent licking the injected hindpaw during the first 20 minutes (5--25 minutes post-LVVA-SM) of the formalin + LVVA-SM group was significantly less than that of the formalin + no LVVA-SM group (^*∗∗*^ *P* \< 0.001) ([Figure 3](#fig3){ref-type="fig"}). The mean licking times of the two groups were not significantly different during the second (*P* = 0.82) and third (*P* = 0.42) 20 minutes post-LVVA-SM.

For the formalin + LVVA-SM group, the mean time spent licking the injected hindpaw was not different between 1--5 minutes after injection and the first 20 minutes post-LVVA-SM (*P* = 0.62), significantly increased during the second 20 minutes (^\#^ *P* = 0.03), and then significantly decreased during the third 20 minutes (^\#\#^ *P* \< 0.001) ([Figure 3](#fig3){ref-type="fig"}). For the formalin + no LVVA-SM group, the mean time spent licking the injected hindpaw significantly increased between 1--5 minutes after injection and the first 20 minutes (^@@^ *P* \< 0.001), did not change during the second 20 minutes (*P* = 0.68), and then significantly decreased during the third 20 minutes (^@@^ *P* \< 0.001) ([Figure 3](#fig3){ref-type="fig"}).

4. Discussion {#sec4}
=============

Studies that identify mechanisms of action are needed to optimize pain relief resulting from spinal manipulative therapies. Basic science research that uses experimental pain models in which simulated spinal manual therapy techniques have antinociceptive effects is essential to these investigations. The present study was designed to determine the antinociceptive effects of a single LVVA-SM treatment on adult rat remote nociceptive behavior. Using the established formalin test, the results show that administering LVVA-SM at 20° flexion for 10 minutes at the anesthetized rat\'s L5 vertebra beginning 10 minutes post-formalin injection significantly decreased hindpaw licking times for the first 20 minutes beginning 5 minutes following the end of treatment.

The results build upon findings from previous basic science and clinical research studies of spinal manipulative therapies that used experimental models of chemically induced inflammation. Three minutes of spinal mobilization was administered at 2 Hz over the nonanesthetized, restrained rat L5 spinous process beginning 10 minutes after intraplantar injection of a mixture of bradykinin, substance P, serotonin, histamine, and prostaglandin E2 into a hindpaw \[[@B19]\]. Pressure pain thresholds of the inflamed hindpaws were increased only when assessed immediately after treatment ended. Administration of HVLA-SM to the human thoracic vertebra 15 minutes after topical application of capsaicin to the forearms immediately reduced evoked secondary hyperalgesia and allodynia as well as perceived pain intensity \[[@B58]\]. When compared to no, sham, and/or placebo interventions, hypoalgesia has also been demonstrated in asymptomatic and symptomatic individuals during assessments performed immediately or 5 minutes following single spinal manipulative therapy treatments \[[@B16], [@B59]--[@B68]\]. In these studies, changes of pressure pain threshold, suprathreshold heat response, temporal sensory summation threshold, and perceived pain intensity were seen remotely at the extremities as well as locally following manipulation or mobilization at the cervical, thoracic, or lumbar vertebrae. Temporal studies also found significant local therapeutic effects on electrical pain tolerance and pressure pain thresholds during assessments 30 seconds--10 minutes and 1--15 minutes following HVLA-SM, respectively \[[@B59], [@B69]\]. Collectively, these results indicate that a single spinal manipulative therapy treatment provides immediate pain relief both remote and local to the anatomical treatment site that persists at short-term follow-up.

What mechanisms may be responsible for LVVA-SM\'s significant attenuation of the nociceptive hindpaw licking behavior during the formalin test? Our findings of short-term remote therapeutic effects add to the literature indicating central nervous system (CNS) involvement \[[@B12], [@B15], [@B52], [@B70]--[@B78]\]. Studies in adult rats demonstrate that spinal cord and supraspinal neurons are activated following formalin injection into the paw and that the extent of activation parallels the nociceptive licking behavior \[[@B79]--[@B82]\]. Therefore, a number of CNS regions playing a role in the formalin-induced nociceptive behaviors likely are involved in LVVA-SM\'s antinociceptive effects.

In particular, central sensitization is induced within spinal cord dorsal horn neurons during the formalin test\'s persistent phase \[[@B83]\]. Temporal summation, a measure of dorsal horn neuron central sensitization, has been shown to be immediately inhibited both remotely and locally in asymptomatic and symptomatic persons following spinal manipulation \[[@B66], [@B68], [@B84], [@B85]\]. Reductions in the number of c-fos expressing lumbar spinal cord dorsal horn neurons activated during the formalin test have been observed following acupuncture and electroacupuncture \[[@B57], [@B86]--[@B89]\]. Importantly, these changes were associated with attenuated nociceptive behaviors including hindpaw licking. Therefore, a mechanism of spinal manipulative therapies may involve alterations of pain-induced neuroplastic changes occurring in the spinal cord. These alterations may be due to inhibitory effects on dorsal horn neurons activated by formalin-induced nociception from increased innocuous afferent input generated by LVVA-SM\'s stimulation of cutaneous and subcutaneous sensory receptors, muscle spindle afferents, and/or Golgi tendon organs \[[@B72], [@B90], [@B91]\].

In concert with these inhibitory afferent mechanisms or independently, descending pain inhibitory systems \[[@B77], [@B78]\] also may be involved. Clinical research using functional magnetic resonance imaging in asymptomatic individuals has demonstrated that decreased remote peripheral pain rating immediately following spinal manipulative therapy was significantly related to reduced neuronal activation in brain regions associated with pain \[[@B92]\]. Basic science research using functional magnetic resonance imaging also showed trends of reduced neuronal activation in brain and lumbar spinal cord regions associated with nociception when knee joint mobilization followed remote ankle joint capsaicin injection \[[@B21], [@B22]\]. Importantly, the hindpaw secondary mechanical hyperalgesia resulting from ankle joint capsaicin injection was reduced following knee joint mobilization \[[@B20]\]. This antinociceptive effect was prevented or attenuated by intrathecal delivery prior to knee joint mobilization of pharmacological agents that blocked lumbar spinal cord neuron monoamine receptors, but not opioid or GABA receptors \[[@B23]\]. Therefore, involvement of descending pain inhibitory mechanisms using serotonin and noradrenaline is indicated for peripheral manipulative therapy \[[@B23]\]. These mechanisms may be applicable to spinal manipulative therapy as well.

5. Limitations {#sec5}
==============

The antinociceptive effect of LVVA-SM during the formalin test\'s persistent phase was short-term. A future step of our basic science research will be to determine whether LVVA-SM\'s antinociceptive effects can last longer and their magnitude can be improved. The present study\'s results may depend upon LVVA-SM\'s dosage parameters. Eighty-two flexion cycles were administered during the clinically relevant duration of 10 minutes \[[@B53]\]. This 0.14 Hz stimulus rate is slower than the 2 Hz spinal mobilization used by Grayson and colleagues \[[@B19]\] for 3 minutes in rats with inflamed hindpaws. Clinical research of spinal mobilization in asymptomatic individuals found that stimulus rates of 1 and 2 Hz delivered to lumbar vertebrae for 3 minutes led to similar immediate increases in pain pressure thresholds assessed both remotely and locally to the treatment site \[[@B93]\]. A stimulus rate of 2 Hz administered to cervical vertebrae for 3 minutes produced a greater increase in skin conductance, but not skin temperature, than 0.5 Hz for 10 minutes after treatment \[[@B94]\]. Furthermore, basic science research of peripheral knee joint mobilization demonstrated that durations of 9 and 15, but not 3, minutes produced antinociception measured at the hindpaw following remote ankle joint nociception \[[@B20]\]. These differing results indicate that systematic evaluation of LVVA-SM\'s dosage parameters and their antinociceptive effects is needed.

The transient duration of nociceptive behaviors during the formalin test\'s persistent phase limits its further use to mechanistic studies of LVVA-SM\'s short-term remote effect. Investigation of LVVA-SM\'s long-term remote antinociceptive effects will require experimental models where nociceptive behaviors last for hours or days, such as in those of peripheral joint or muscle pain in which long-term antinociceptive effects of knee joint mobilization have been found \[[@B20], [@B23], [@B24]\]. A model of chronic peripheral neuropathic pain \[[@B95]\] may be useful as well.

The individual assessing the time spent licking the hindpaw was not blinded to group assignment. Therefore, the risk of assessor bias could be considered a limitation of our study despite hindpaw licking time being an objective outcome measure. It was not possible to perform LVVA-SM in conscious rats due to the stress that may result and stress-induced analgesia \[[@B96]\]. While spinal manipulative therapies can be clinically delivered under anesthesia \[[@B97]\] and anesthesia has been used during manual therapy in previous studies of laboratory rats \[[@B20], [@B86]\], administering LVVA-SM to anesthetized rats may be a limitation of our study. However, we included an anesthetized control group to account for this possibility. Our choice of isoflurane was based upon the finding that rat nociceptive behavior was modestly attenuated during the formalin test\'s persistent phase following isoflurane administration \[[@B98]\].

6. Conclusion {#sec6}
=============

The present study shows that lumbar LVVA-SM administration to adult rats during the formalin test is capable of reducing remote nociceptive behavior for a short-term. Since this result is similar to clinical research findings, mechanistic investigations of LVVA-SM\'s short-term remote antinociceptive effect can using the formalin test are warranted.
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![The LVVA-SM technique as performed clinically.](ECAM2015-520454.001){#fig1}

![An anesthetized rat undergoing LVVA-SM on a custom-made, motorized device. Mild vertebral column traction was provided using an incisor bar in the anesthesia nose cone (A) and a 100 g weight (B). Mild pressure was applied at the L5 spinous process (C).](ECAM2015-520454.002){#fig2}

![Temporal changes of hindpaw licking behavior following intraplantar formalin injection and either LVVA-SM (formalin + LVVA-SM, *n* = 12) or no LVVA-SM (formalin + no LVVA-SM, *n* = 12). Data are presented as means and 95% confidence intervals (CI) from the linear mixed model. The mean time spent licking the injected hindpaw during the first 20 minutes (min) of 5--65 min post-LVVA-SM by the formalin + LVVA-SM group was less than that of the formalin + no LVVA-SM group (^*∗∗*^ *P* \< 0.001 at 25 min post-LVVA-SM). ^@@^ *P* \< 0.001, ^\#^ *P* = 0.03, and ^\#\#^ *P* \< 0.001.](ECAM2015-520454.003){#fig3}
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